Centennial Bank’s Novartis NVS Stock Holding History

Centennial Bank’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$76.4K	Hold	500	–	–	0.03%	192
2025 Q4	$68.9K	Hold	500	–	–	0.03%	197
2025 Q3	$64.1K	Hold	500	–	–	0.03%	194
2025 Q2	$60.5K	Sell	500 -20	-4%	-$2.25K	0.03%	200
2025 Q1	$58K	Sell	520 -25	-5%	-$2.66K	0.03%	193
2024 Q4	$53K	Hold	545	–	–	0.03%	194
2024 Q3	$62.7K	Hold	545	–	–	0.03%	187
2024 Q2	$58K	Sell	545 -107	-16%	-$10.7K	0.03%	180
2024 Q1	$63.1K	Sell	652 -128	-16%	-$13.1K	0.03%	175
2023 Q4	$78.8K	Buy	780 +194	+33%	+$18.7K	0.05%	165
2023 Q3	$59.7K	Buy	586 +561	+2,244%	+$56.9K	0.04%	178
2023 Q2	$2.52K	Hold	25	–	–	﹤0.01%	311
2023 Q1	$2.3K	Sell	25 -28	-53%	-$2.44K	﹤0.01%	305
2022 Q4	$4.81K	Buy	+53	New	+$4.46K	﹤0.01%	309

Other funds holding NVS

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Centennial Bank's NVS Position: Q1 2026 in Review

Centennial Bank held its Novartis (NVS) position steady in Q1 2026 at 500 shares worth $76.4K. The position accounts for 0.03% of the portfolio, ranked #192.

Centennial Bank first reported a position in NVS in Q4 2022 and has held it in 14 quarters since. The position peaked at $78.8K in Q4 2023. 1,592 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

Centennial Bank held 500 shares of Novartis worth $76.4K as of Q1 2026.
Centennial Bank left its Novartis share count unchanged in Q1 2026.
Novartis made up 0.03% of Centennial Bank's portfolio in Q1 2026, its #192 holding.
Centennial Bank first reported a position in Novartis in Q4 2022 and has held it in 14 quarters since.
Centennial Bank's Novartis position peaked at $78.8K in Q4 2023.
1,592 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on Centennial Bank's 13F filing for Q1 2026, filed 6 May 2026.